patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Thank Emit!

Emma,

We're very lucky to have someone on this board who knows these stocks as well as you do and can determine when they will pay-off with such certainty. I hope at least one of the stocks makes it.

PTSC is one USPTO re-exam decision away from paying-off. Who knows how long it will take for that decision to be made by the USPTO? I'm sure you probably know.

Share
New Message
Please login to post a reply